<< ONE launches clinical software and business services for medical billing companies and physician groups | School intervention programs may promote psychological well-being among adolescents >>

Read in | English | Deutsch | 简体中文 | עִבְרִית

ZEGERID OTC approval triggers $20M milestone payment to Santarus

Published on December 22, 2009 at 4:40 AM · No Comments

Santarus, Inc. (NASDAQ:SNTS), a specialty biopharmaceutical company, today announced that it has received the $20 million milestone payment previously announced on December 1, 2009 relating to the approval of ZEGERID OTC^™ (omeprazole 20 mg/sodium bicarbonate 1100 mg capsules) under its over-the-counter (OTC) licensing agreement with Schering-Plough HealthCare Products, Inc., the consumer healthcare division of Merck & Co., Inc. Schering-Plough and Merck merged on November 3, 2009.

The U.S. Food and Drug Administration (FDA) approved Schering-Plough HealthCare Products’ New Drug Application (NDA) for ZEGERID OTCfor OTC treatment of frequent heartburn on December 1, 2009. The OTC heartburn market in the U.S. is estimated at $1.7 billion based on data from Information Resources, Inc., a market research firm, and company estimates. ZEGERID OTC capsules are expected to be available on retail store shelves in the first half of 2010.

Continued on Next page >>

Related posts

Weight gain and other metabolic side effects of bipolar and schizophrenia drugs may be counteredA new study suggests that young people who are diagnosed with bipolar disorder and schizophrenia may...
FDA sets Feb. 9 for ODAC meeting to review CTI's resubmitted pixantrone NDACell Therapeutics, Inc. (CTI) announced today that on February 9, 2012 the U.S. Food and Drug Admini...
New study: Insulin signaling is altered in human pancreasInsulin signaling is altered in the pancreas, a new study shows for the first time in humans. The er...
FDA approves Gilead's Complera for treatment of HIV-1 infectionGilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Watson, GeneraMedix receive FDA approval for Nulecit to treat iron deficiency anemiaWatson Pharmaceuticals, Inc. today announced that it is initiating launch activities of Nulecit, fol...
NextGen executes agreement with MKMG to deploy EHR solutionNextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. and...
Study explores role of genetic influence on ulcerative colitisAdults diagnosed with ulcerative colitis after age 50 are more likely to achieve remission from thei...
Merck challenges New York jury decision in federal FOSAMAX retrialMerck & Co., Inc. today said it is challenging the decision returned by a New York jury in the retri...
Updated phase II study results of OPAXIO in patients with advanced esophageal cancerCell Therapeutics, Inc. announced today that updated phase II study results of OPAXIO (paclitaxel po...
Perrigo acquires rights to ANDA for HalfLytely and Bisacodyl Tablets Bowel Prep KitPerrigo Company today announced that it has acquired rights to Novel Laboratories' pending ANDA for ...
Results of study comparing REMICADE to azathioprine for Crohn's disease publishedFindings published today in The New England Journal of Medicine from a first-of-its-kind comparator ...
Impax Laboratories initiates patent challenge for TRICORImpax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed by A...
Two common biomarkers help predict stroke riskTwo common biomarkers have now been shown to improve the ability to predict who will suffer from a s...
Talk therapy works for panic disorderPsychoanalytic therapies have been in professional use for over a century, but a new study from phys...
Acid reflux disease - surgery has longterm success rateAccording to a study published this week, surgery to cure acid reflux disease, the most severe form ...
Folic acid improves memory and protects the brain from agingAccording to scientists in Holland high doses of folic acid might help slow the cognitive decline of...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.